Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-21-011225

EVP, Chief Scientific Officer acquired 9,084 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Shearman Mark S · EVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-22 Grant or award : show line 1 in the form +9,084 41,785 D
Loading xslF345X03/edgar.xml…